Events

Recall of Alere INRatio & INRatio 2 PT/INR Monitoring System

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Alere San Diego Inc.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    17852
  • Event Initiated Date
    2014-12-24
  • Event Country
    New Zealand
  • Event Source
    NZMMDSA
  • Event Source URL
    https://medsafe.govt.nz/hot/Recalls/RecallSearch.asp
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Alere Ltd, C/- Bell Gully, Level 22, Vero Centre, 48 Shortland Street, AUCKLAND 1010
  • Reason
    The inratio® and inratio®2 pt/inr monitor system should not be used on patients with any of the following conditions:, * anemia of any type with hematocrit less than 30%, * any conditions associated with elevated fibrinogen levels including:, - acute inflammatory conditions (examples may include acute viral or bacterial infections such as pneumonia or influenza), - chronic inflammatory conditions (examples may include rheumatoid arthritis, crohn's disease, ulcerative colitis, infectious liver diseases such as hepatitis, or inflammatory kidney diseases such as diabetic nephropathy and glomerulonephritis), - severe infection (e.G., sepsis), - chronically elevated fibrinogen for any reason, - hospitalized or advanced stage cancer or end stage renal disease patients requiring hemodialysis, * any bleeding or unusual bruising, clinically observed or reported by the patient.
  • Action
    Manufacturer to issue advice regarding use

Device

Alere INRatio & INRatio 2 PT/INR Monitoring System

Manufacturer

Alere San Diego Inc
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    NZMMDSA